Yüklüyor......
Regulatory T cells move in when gliomas say “I-DO”
Indoleamine 2,3-dioxygenase (IDO) is an enzyme with known immunosuppressive and tolerogenic effects in cancer. Mounting evidence has associated IDO expression with the induction of regulatory T cells and malignant progression. IDO inhibition may therefore provide a promising therapeutic approach for...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3662964/ https://ncbi.nlm.nih.gov/pubmed/23052252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2801 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|